IT
Ingenia Therapeutics
Shutdowningeniatherapeutics.com
Website unreachable since Oct 16, 2026
Ingenia Therapeutics is developing a therapeutic antibody candidate specifically targeting capillary diseases, utilizing advanced antibody engineering techniques to enhance specificity and efficacy. This approach aims to provide a targeted treatment option for patients suffering from conditions related to capillary dysfunction.
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$17MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Ingenia Therapeutics is developing a therapeutic antibody candidate specifically targeting capillary diseases, utilizing advanced antibody engineering techniques to enhance specificity and efficacy. This approach aims to provide a targeted treatment option for patients suffering from conditions related to capillary dysfunction.